The 10% of AI Projects That Drive 80% of Results

The "AI everywhere" industry mindset is slowly shifting where disciplined, value-driven implementation beats scattered experimentation every time. Some organizations are pursuing dozens of AI use cases only to find that the top 10% drive 80% of the actual value, while others are laser-focused on high-impact applications that actually move the needle. Join two industry leaders who've taken action to focus on applications that deliver real results: accelerating drug discovery timelines, optimizing supply chains that save millions, and enhancing clinical decision-making that improves patient outcomes. Let’s figure out why only 25% of companies are seeing ROI from their AI investments despite billions in spending. If your goal is to balance rapid experimentation with regulatory reality, escape the endless planning trap to build working prototypes, and transform your IT department from order-takers into strategic drivers of business value, we’ve got you covered. It’s time to shatter the myth that regulation is pharma's biggest innovation bottleneck!